poisar

Stocks · News reference

Barclays Maintains Overweight on Danaher, Raises Price Target to $255

BenzingaBenzinga Newsdesk

Barclays analyst Luke Sergott maintains Danaher (NYSE:DHR) with a Overweight and raises the price target from $230 to $255.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Zacks Investment ResearchNa

    Danaher (DHR) Earnings Expected to Grow: Should You Buy?

    Danaher (DHR) is positioned as a likely earnings beat candidate for Q3 2026 with an Earnings ESP of +0.30% and Zacks Rank #2 (Buy). The company is expected to report EPS of $1.92 (up 1.6% YoY) and revenues of $6.55 billion (up 8.2% YoY). With a history of beating consensus estimates in the last four quarters, the stock appears well-positioned for positive price movement following its October 21 earnings release.